Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

Araceli makes hardware and software, which includes AI analysis, used by customers in pharmaceutical drug discovery.

The round also saw participation from Huddle, Campus Fund, Blume Founders Fund, and angel investors including Nitin Sharma (Nexus Venture Partners) and Sameer Brij Verma (Northpoint Capital).

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...

Over the next four months, the Vaccine Integrity Project will hold information-gathering sessions with medical associations, public health organizations, state health officials, vaccine manufacturers, ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...

BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally ...

Dire wolves — or really, wolves with traits like the extinct species — are back. But New York has plenty of its own ...

AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...